Index by author

01 September 2005; volume 26, issue 3

A

  1. Aaron, S. D.

    1. Parker, C. M. et al "Physiological changes during symptom recovery from moderate exacerbations of COPD." European Respiratory Journal 26.3 (2005): 420-428. Web. 18 Feb. 2020.

  2. Abramson, M. J.

    1. James, A. L. et al "Time to death, airway wall inflammation and remodelling in fatal asthma." European Respiratory Journal 26.3 (2005): 429-434. Web. 18 Feb. 2020.

  3. Aine, T.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  4. Andersen, C. B.

    1. Milman, N. et al "Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells." European Respiratory Journal 26.3 (2005): 549-552. Web. 18 Feb. 2020.

  5. Arts, I. C. W.

    1. Garcia, V. et al "Dietary intake of flavonoids and asthma in adults." European Respiratory Journal 26.3 (2005): 449-452. Web. 18 Feb. 2020.

  6. Aubert, A.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

B

  1. Bai, G. H.

    1. Koh, W-J. et al "Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis." European Respiratory Journal 26.3 (2005): 557. Web. 18 Feb. 2020.

  2. Bakke, P.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  3. Barberà, J. A.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  4. Barnes, P. J.

    1. Horváth, I., J. Hunt, and P. J. Barnes. "Exhaled breath condensate: methodological recommendations and unresolved questions." European Respiratory Journal 26.3 (2005): 523-548. Web. 18 Feb. 2020.

  5. Berger, R. M. F.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

  6. Bingham, S. A.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  7. Bommeljé, C.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  8. Bonsignore, G.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  9. Bousquet, J.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  10. Boyce, P.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

  11. Brambilla, C.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  12. Brambilla, E.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  13. Brichon, P. Y.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  14. Brøndum, E.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  15. Bruno, A.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  16. Brusasco, V.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  17. Burgos, F.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  18. Burton, C. M.

    1. Milman, N. et al "Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells." European Respiratory Journal 26.3 (2005): 549-552. Web. 18 Feb. 2020.

C

  1. Calverley, P.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  2. Campana, S.

    1. Taccetti, G. et al "Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients." European Respiratory Journal 26.3 (2005): 458-461. Web. 18 Feb. 2020.

  3. Carlsson, L-G.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  4. Casaburi, R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  5. Casas, A.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  6. Chanez, P.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  7. Chau, P. H.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  8. Chiappara, G.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  9. Christiani, D. C.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

  10. Clausen, J. L.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  11. Clifton, V. L.

    1. Murphy, V. E. et al "Asthma self-management skills and the use of asthma education during pregnancy." European Respiratory Journal 26.3 (2005): 435-441. Web. 18 Feb. 2020.

  12. Coates, A.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  13. Crapo, R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  14. Cromme-Dijkhuis, A. H.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

D

  1. Dahlén, B.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  2. Dahlén, S-E.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  3. Day, N. E.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  4. de Jongste, J. C.

    1. de Jongste, J. C.. "Yes to NO: the first studies on exhaled nitric oxide-driven asthma treatment." European Respiratory Journal 26.3 (2005): 379-381. Web. 18 Feb. 2020.
    2. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  5. De Sanctis, J.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  6. Diab, S.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  7. Diel, R.

    1. Diel, R., A. Nienhaus, and T. Schaberg. "Cost-effectiveness of isoniazid chemoprevention in close contacts." European Respiratory Journal 26.3 (2005): 465-473. Web. 18 Feb. 2020.

  8. Don, M.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  9. Döring, G.

    1. Taccetti, G. et al "Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients." European Respiratory Journal 26.3 (2005): 458-461. Web. 18 Feb. 2020.

E

  1. Elliot, J. G.

    1. James, A. L. et al "Time to death, airway wall inflammation and remodelling in fatal asthma." European Respiratory Journal 26.3 (2005): 429-434. Web. 18 Feb. 2020.

  2. Enright, P.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.
    2. Enright, P.. " From the author ." European Respiratory Journal 26.3 (2005): 559. Web. 18 Feb. 2020.

F

  1. Faustini, A.

    1. Faustini, A., A. J. Hall, and C. A. Perucci. "Tuberculosis treatment outcomes in Europe: a systematic review." European Respiratory Journal 26.3 (2005): 503-510. Web. 18 Feb. 2020.

  2. Feenstra, L.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  3. Festini, F.

    1. Taccetti, G. et al "Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients." European Respiratory Journal 26.3 (2005): 458-461. Web. 18 Feb. 2020.

  4. Fourneret, P.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

G

  1. Garcia, V.

    1. Garcia, V. et al "Dietary intake of flavonoids and asthma in adults." European Respiratory Journal 26.3 (2005): 449-452. Web. 18 Feb. 2020.

  2. Giammanco, S.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  3. Gibson, P. G.

    1. Murphy, V. E. et al "Asthma self-management skills and the use of asthma education during pregnancy." European Respiratory Journal 26.3 (2005): 435-441. Web. 18 Feb. 2020.

  4. Gislason, T.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  5. Gjomarkaj, M.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  6. Gómez, F. P.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  7. Gong, M. N.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

  8. Gudmundsson, G.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  9. Gustafsson, P.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

H

  1. Hall, A. J.

    1. Faustini, A., A. J. Hall, and C. A. Perucci. "Tuberculosis treatment outcomes in Europe: a systematic review." European Respiratory Journal 26.3 (2005): 503-510. Web. 18 Feb. 2020.

  2. Hallin, R.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  3. Hankinson, J.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  4. Hernández, N.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  5. Higenbottam, T.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  6. Ho, J. C.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  7. Ho, P. L.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  8. Holz, O.

    1. Holz, O.. "Catching breath: monitoring airway inflammation using exhaled breath condensate." European Respiratory Journal 26.3 (2005): 371-372. Web. 18 Feb. 2020.

  9. Horváth, I.

    1. Horváth, I., J. Hunt, and P. J. Barnes. "Exhaled breath condensate: methodological recommendations and unresolved questions." European Respiratory Journal 26.3 (2005): 523-548. Web. 18 Feb. 2020.

  10. Hunt, J.

    1. Horváth, I., J. Hunt, and P. J. Barnes. "Exhaled breath condensate: methodological recommendations and unresolved questions." European Respiratory Journal 26.3 (2005): 523-548. Web. 18 Feb. 2020.

I

  1. Iversen, M.

    1. Milman, N. et al "Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells." European Respiratory Journal 26.3 (2005): 549-552. Web. 18 Feb. 2020.

J

  1. James, A. L.

    1. James, A. L. et al "Time to death, airway wall inflammation and remodelling in fatal asthma." European Respiratory Journal 26.3 (2005): 429-434. Web. 18 Feb. 2020.

  2. Janson, C.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  3. Janssens, J-P.

    1. Younossian, A. B. et al "High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis." European Respiratory Journal 26.3 (2005): 462-464. Web. 18 Feb. 2020.

  4. Jensen, R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  5. Johnson, D.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  6. Jones, A. M.

    1. Jones, A. M.. "Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered." European Respiratory Journal 26.3 (2005): 373-375. Web. 18 Feb. 2020.

K

  1. Kaw, G. J. L.

    1. Tay, N. S. W. T. et al "Tuberculosis mimicry." European Respiratory Journal 26.3 (2005): 554-556. Web. 18 Feb. 2020.

  2. Kemna, M. S.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

  3. Kessell, C. G.

    1. Murphy, V. E. et al "Asthma self-management skills and the use of asthma education during pregnancy." European Respiratory Journal 26.3 (2005): 435-441. Web. 18 Feb. 2020.

  4. Ketterer, J-P.

    1. Younossian, A. B. et al "High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis." European Respiratory Journal 26.3 (2005): 462-464. Web. 18 Feb. 2020.

  5. Khaw, K-T.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  6. Khong, P. L.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  7. Ko, C.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  8. Koh, W-J.

    1. Koh, W-J. et al "Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis." European Respiratory Journal 26.3 (2005): 557. Web. 18 Feb. 2020.

  9. Kwon, O. J.

    1. Koh, W-J. et al "Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis." European Respiratory Journal 26.3 (2005): 557. Web. 18 Feb. 2020.

L

  1. Lantuejoul, S.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  2. Lew, W. J.

    1. Koh, W-J. et al "Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis." European Respiratory Journal 26.3 (2005): 557. Web. 18 Feb. 2020.

  3. Lindberg, E.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  4. Löfdahl, C-G.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  5. Luben, R. N.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

M

  1. MacIntyre, N.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  2. Mantingh, C. J.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  3. Mascherini, M.

    1. Taccetti, G. et al "Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients." European Respiratory Journal 26.3 (2005): 458-461. Web. 18 Feb. 2020.

  4. Mata, A.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  5. McKay, R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  6. Miller, M. R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  7. Milman, N.

    1. Milman, N. et al "Recurrent sarcoid granulomas in a transplanted lung derive from recipient immune cells." European Respiratory Journal 26.3 (2005): 549-552. Web. 18 Feb. 2020.

  8. Montes de Oca, M.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  9. Moro-Sibilot, D.

    1. Moro-Sibilot, D. et al "Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer." European Respiratory Journal 26.3 (2005): 480-486. Web. 18 Feb. 2020.

  10. Murphy, V. E.

    1. Murphy, V. E. et al "Asthma self-management skills and the use of asthma education during pregnancy." European Respiratory Journal 26.3 (2005): 435-441. Web. 18 Feb. 2020.

  11. Myint, P. K.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

N

  1. Navajas, D.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  2. Nieminen, M. M.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

  3. Nienhaus, A.

    1. Diel, R., A. Nienhaus, and T. Schaberg. "Cost-effectiveness of isoniazid chemoprevention in close contacts." European Respiratory Journal 26.3 (2005): 465-473. Web. 18 Feb. 2020.

O

  1. O'Donnell, D. E.

    1. Parker, C. M. et al "Physiological changes during symptom recovery from moderate exacerbations of COPD." European Respiratory Journal 26.3 (2005): 420-428. Web. 18 Feb. 2020.

  2. Ong, K. C.

    1. Tay, N. S. W. T. et al "Tuberculosis mimicry." European Respiratory Journal 26.3 (2005): 554-556. Web. 18 Feb. 2020.

  3. Ooi, G. C.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

P

  1. Park, Y. K.

    1. Koh, W-J. et al "Development of multidrug resistance during treatment of isoniazid-resistant tuberculosis." European Respiratory Journal 26.3 (2005): 557. Web. 18 Feb. 2020.

  2. Parker, C. M.

    1. Parker, C. M. et al "Physiological changes during symptom recovery from moderate exacerbations of COPD." European Respiratory Journal 26.3 (2005): 420-428. Web. 18 Feb. 2020.

  3. Pauwels, R.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  4. Pedersen, O. F.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  5. Pellegrino, R.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  6. Perucci, C. A.

    1. Faustini, A., A. J. Hall, and C. A. Perucci. "Tuberculosis treatment outcomes in Europe: a systematic review." European Respiratory Journal 26.3 (2005): 503-510. Web. 18 Feb. 2020.

  7. Pothier, L.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

R

  1. Roca, J.

    1. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

  2. Rochat, T.

    1. Younossian, A. B. et al "High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis." European Respiratory Journal 26.3 (2005): 462-464. Web. 18 Feb. 2020.

  3. Rodríguez-Roisin, R.

    1. Rodríguez-Roisin, R.. "Is this the beginning of unravelling the puzzle of COPD exacerbations?." European Respiratory Journal 26.3 (2005): 376-378. Web. 18 Feb. 2020.
    2. Casas, A. et al "Leukotriene D4-induced hypoxaemia in asthma is mediated by the cys-leukotriene1 receptor." European Respiratory Journal 26.3 (2005): 442-448. Web. 18 Feb. 2020.

S

  1. Schaberg, T.

    1. Diel, R., A. Nienhaus, and T. Schaberg. "Cost-effectiveness of isoniazid chemoprevention in close contacts." European Respiratory Journal 26.3 (2005): 465-473. Web. 18 Feb. 2020.

  2. Schoemaker, R. G.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

  3. Shaheen, S. O.

    1. Garcia, V. et al "Dietary intake of flavonoids and asthma in adults." European Respiratory Journal 26.3 (2005): 449-452. Web. 18 Feb. 2020.

  4. Siena, L.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  5. Ståhl, E.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

  6. Sterne, J. A. C.

    1. Garcia, V. et al "Dietary intake of flavonoids and asthma in adults." European Respiratory Journal 26.3 (2005): 449-452. Web. 18 Feb. 2020.

  7. Struben, V. M. D.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  8. Surtees, P. G.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  9. Svensson, K.

    1. Calverley, P. et al "Relationship between respiratory symptoms and medical treatment in exacerbations of COPD." European Respiratory Journal 26.3 (2005): 406-413. Web. 18 Feb. 2020.

T

  1. Taccetti, G.

    1. Taccetti, G. et al "Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients." European Respiratory Journal 26.3 (2005): 458-461. Web. 18 Feb. 2020.

  2. Tálamo, C.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  3. Talbot, P. I.

    1. Murphy, V. E. et al "Asthma self-management skills and the use of asthma education during pregnancy." European Respiratory Journal 26.3 (2005): 435-441. Web. 18 Feb. 2020.

  4. Tan, S. Y.

    1. Tay, N. S. W. T. et al "Tuberculosis mimicry." European Respiratory Journal 26.3 (2005): 554-556. Web. 18 Feb. 2020.

  5. Tay, N. S. W. T.

    1. Tay, N. S. W. T. et al "Tuberculosis mimicry." European Respiratory Journal 26.3 (2005): 554-556. Web. 18 Feb. 2020.

  6. Thompson, B. T.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

  7. Thompson, R. L.

    1. Garcia, V. et al "Dietary intake of flavonoids and asthma in adults." European Respiratory Journal 26.3 (2005): 449-452. Web. 18 Feb. 2020.

  8. Torres, S. H.

    1. Montes de Oca, M. et al "Skeletal muscle inflammation and nitric oxide in patients with COPD." European Respiratory Journal 26.3 (2005): 390-397. Web. 18 Feb. 2020.

  9. Tsang, K. W.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

U

  1. Ulrik, C. S.

    1. Gudmundsson, G. et al "Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression." European Respiratory Journal 26.3 (2005): 414-419. Web. 18 Feb. 2020.

V

  1. van Albada, M. E.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

  2. van der Grinten, C. P. M.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  3. van Veghel, R.

    1. van Albada, M. E. et al "The role of increased pulmonary blood flow in pulmonary arterial hypertension." European Respiratory Journal 26.3 (2005): 487-493. Web. 18 Feb. 2020.

  4. Viegi, G.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  5. Vignola, A. M.

    1. Bruno, A. et al "Does leptin play a cytokine-like role within the airways of COPD patients?." European Respiratory Journal 26.3 (2005): 398-405. Web. 18 Feb. 2020.

  6. Voduc, N.

    1. Parker, C. M. et al "Physiological changes during symptom recovery from moderate exacerbations of COPD." European Respiratory Journal 26.3 (2005): 420-428. Web. 18 Feb. 2020.

W

  1. Wacker, J.

    1. Younossian, A. B. et al "High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis." European Respiratory Journal 26.3 (2005): 462-464. Web. 18 Feb. 2020.

  2. Wainwright, N. W. J.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  3. Walters, E. H.

    1. James, A. L. et al "Time to death, airway wall inflammation and remodelling in fatal asthma." European Respiratory Journal 26.3 (2005): 429-434. Web. 18 Feb. 2020.

  4. Wanger, J.

    1. Wanger, J. et al "Standardisation of the measurement of lung volumes." European Respiratory Journal 26.3 (2005): 511-522. Web. 18 Feb. 2020.

  5. Wareham, N. J.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  6. Webb, K. A.

    1. Parker, C. M. et al "Physiological changes during symptom recovery from moderate exacerbations of COPD." European Respiratory Journal 26.3 (2005): 420-428. Web. 18 Feb. 2020.

  7. Welch, A. A.

    1. Myint, P. K. et al "Respiratory function and self-reported functional health: EPIC-Norfolk population study." European Respiratory Journal 26.3 (2005): 494-502. Web. 18 Feb. 2020.

  8. White, P.

    1. White, P.. "Should we use spirometry in the early detection of COPD?." European Respiratory Journal 26.3 (2005): 558-559. Web. 18 Feb. 2020.

  9. Wieringa, M. H.

    1. Struben, V. M. D. et al "Nasal NO: normal values in children age 6 through to 17 years." European Respiratory Journal 26.3 (2005): 453-457. Web. 18 Feb. 2020.

  10. Williams, P. L.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.

  11. Wong, P. C.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

Y

  1. Yan, C.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  2. Yip, P. S. F.

    1. Ho, P. L. et al "A prediction rule for clinical diagnosis of severe acute respiratory syndrome." European Respiratory Journal 26.3 (2005): 474-479. Web. 18 Feb. 2020.

  3. Younossian, A. B.

    1. Younossian, A. B. et al "High hepatotoxicity of pyrazinamide and ethambutol for treatment of latent tuberculosis." European Respiratory Journal 26.3 (2005): 462-464. Web. 18 Feb. 2020.

Z

  1. Zhou, W.

    1. Gong, M. N. et al "−308GA and TNFB polymorphisms in acute respiratory distress syndrome." European Respiratory Journal 26.3 (2005): 382-389. Web. 18 Feb. 2020.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts